Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study

被引:22
作者
Navarro-Penalver, Marina [1 ]
Teresa Perez-Martinez, M. [1 ]
Gomez-Bueno, Manuel [2 ,3 ]
Garcia-Pavia, Pablo [2 ,3 ]
Lupon-Roses, Josep [1 ,4 ]
Roig-Minguell, Eulalia [5 ]
Comin-Colet, Josep [6 ,7 ]
Bayes-Genis, Antoni [3 ,4 ]
Noguera, Jose A. [1 ]
Pascual-Figal, Domingo A. [1 ,3 ,8 ]
机构
[1] Hosp Clin Univ Virgen de la Arrixaca, Murcia, Spain
[2] Hosp Univ Puerta del Hierro, Madrid, Spain
[3] CIBERCV Inst Salud Carlos III, Madrid, Spain
[4] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
[5] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[6] Hosp Univ Bellvitge, Barcelona, Spain
[7] IDIBELL, Barcelona, Spain
[8] Univ Murcia, Dept Cardiol, IMIB Arrixaca, Murcia, Spain
关键词
testosterone; heart failure; anabolism; randomized; HORMONE DEFICIENCY; MEN; ASSOCIATION; PREVALENCE; MORTALITY; TRIAL;
D O I
10.1177/1074248418784020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Testosterone deficiency is associated with heart failure (HF) progression and poor prognosis. Testosterone therapy has been shown to improve exercise capacity in patients with chronic HF, but no trial has evaluated the impact of replacement in patients with demonstrated testosterone deficiency. Methods: Prospective, randomized, double-blind, placebo-controlled, and parallel-group trial comparing testosterone replacement with placebo in males with chronic HF with reduced ejection fraction (HFrEF) and testosterone deficiency (NCT01813201). Long-acting undecanoate testosterone at a fixed dose of 1000 mg was supplied by intramuscular injection at inclusion and then every 3 months. The placebo group received isotonic saline serum. Patients were randomly allocated 1:1 to testosterone or placebo while receiving optimal medical therapy, and the study was conducted for 12 months. Results: The final sample comprised 29 patients, 15 in the placebo group and 14 in the testosterone group (aged 65 8, 62% with an ischemic etiology, left ventricular ejection fraction [LVEF] 30% +/- 6%, 69% New York Heart Association functional [NYHA II]). After 12 months, testosterone replacement increased testosterone levels (P = .002) but was not associated with benefit in terms of clinical symptoms and functional capacity including NYHA class, Framingham score, Minnesota Living Heart Failure Questionnaire, 6-minute walk test, or LVEF and N-terminal pro-B-type natriuretic peptide levels. No significant side effects associated with testosterone treatment were observed. No effects were found in other hormonal, metabolic, and bone turnover biomarkers. Conclusion: In patients with HFrEF and testosterone deficiency, replacement therapy was not associated with any significant improvement.
引用
收藏
页码:543 / 550
页数:8
相关论文
共 25 条
[1]   Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic review [J].
Albert, Stewart G. ;
Morley, John E. .
CLINICAL ENDOCRINOLOGY, 2016, 85 (03) :436-443
[2]  
Anker SD, 1997, CIRCULATION, V96, P526
[3]   Testosterone: A Novel Therapeutic Approach in Chronic Heart Failure? [J].
Aukrust, Pal ;
Ueland, Thor ;
Gullestad, Lars ;
Yndestad, Arne .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (10) :928-929
[4]   Nontranscriptional regulation of cardiac repolarization currents by testosterone [J].
Bai, CX ;
Kurokawa, J ;
Tamagawa, M ;
Nakaya, H ;
Furukawa, T .
CIRCULATION, 2005, 112 (12) :1701-1710
[5]   Effect of Long-Acting Testosterone Treatment on Functional Exercise Capacity, Skeletal Muscle Performance, Insulin Resistance, and Baroreflex Sensitivity in Elderly Patients With Chronic Heart Failure A Double-Blind, Placebo-Controlled, Randomized Study [J].
Caminiti, Giuseppe ;
Volterrani, Maurizio ;
Iellamo, Ferdinando ;
Marazzi, Giuseppe ;
Massaro, Rosalba ;
Miceli, Marco ;
Mammi, Caterina ;
Piepoli, Massimo ;
Fini, Massimo ;
Rosano, Giuseppe M. C. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (10) :919-927
[6]   Growth Hormone Replacement Delays the Progression of Chronic Heart Failure Combined With Growth Hormone Deficiency An Extension of a Randomized Controlled Single-Blind Study [J].
Cittadini, Antonio ;
Marra, Alberto M. ;
Arcopinto, Michele ;
Bobbio, Emanuele ;
Salzano, Andrea ;
Sirico, Domenico ;
Napoli, Raffaele ;
Colao, Annamaria ;
Longobardi, Salvatore ;
Baliga, Ragavendra R. ;
Bossone, Eduardo ;
Sacca, Luigi .
JACC-HEART FAILURE, 2013, 1 (04) :325-330
[7]   Testosterone and Cardiovascular Health [J].
Elagizi, Andrew ;
Kohler, Tobias S. ;
Lavie, Carl J. .
MAYO CLINIC PROCEEDINGS, 2018, 93 (01) :83-100
[8]   Increased prevalence of prolonged QT interval in males with primary or secondary hypogonadism: A pilot study [J].
Giraldi, F. Pecori ;
Toja, P. M. ;
Filippini, B. ;
Michailidis, J. ;
Scacchi, M. ;
Badiale, M. Stramba ;
Cavagnini, F. .
INTERNATIONAL JOURNAL OF ANDROLOGY, 2010, 33 (01) :E132-E138
[9]   Testosterone Therapy in Women With Chronic Heart Failure A Pilot Double-Blind, Randomized, Placebo-Controlled Study [J].
Iellamo, Ferdinando ;
Volterrani, Maurizio ;
Caminiti, Giuseppe ;
Karam, Roger ;
Massaro, Rosalba ;
Fini, Massimo ;
Collins, Peter ;
Rosano, Giuseppe M. C. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (16) :1310-1316
[10]   Anabolic deficiency in men with chronic heart failure - Prevalence and detrimental impact on survival [J].
Jankowska, Ewa A. ;
Biel, Bartosz ;
Majda, Jacek ;
Szklarska, Alicja ;
Lopuszanska, Monika ;
Medras, Marek ;
Anker, Stefan D. ;
Banasiak, Waldemar ;
Poole-Wilson, Philip A. ;
Ponikowski, Piotr .
CIRCULATION, 2006, 114 (17) :1829-1837